Table1.
FDA-approved antiretroviral therapies
| GenericName | TradeName |
|---|---|
| Nucleoside reverse transcriptase inhibitors | |
| Abacavir (ABC) | Ziagen |
| Didanosine (ddI) | Videx |
| Emtricitabine (FTC) | Emtriva |
| Lamivudine (3TC) | Epivir |
| Stavudine (d4T) | Zerit |
| Tenofovir (TDF) | Viread |
| Zalcitabine (ddC) withdrawn 2005 | Hivid |
| Zidovudine (ZDV or AZT) | Retrovir |
| 3TC/ABC | Epzicom |
| 3TC/ABC/ZDV | Trizivir |
| 3TC/ZDV | Combivir |
| FTC/TDF | Truvada |
| Non-nucleoside reverse transcriptase inhibitors | |
| Delavirdine (DLV) | Rescriptor |
| Efavirenz (EFV) | Sustiva |
| Nevirapine (NVP) | Viramune |
| Etravirine (ETV) | Intelence |
| Multiple Class Fixed Dose Combination | |
| Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) Atripla | |
| Protease inhibitors | |
| Amprenavir (APV) discontinued 2004 | Agenerase |
| Atazanavir (ATV) | Reyataz |
| Darunavir (DRV) | Prezista |
| Fosamprenavir (FPV) | Lexiva |
| Indinavir (IDV) | Crixivan |
| Lopinavir/ritonavir (LPV/RTV) | Kaletra |
| Nelfinavir (NFV) | Viracept |
| Ritonavir (RTV) | Norvir |
| Saquinavir (SQV hgc) | Invirase |
| Tipranavir (TPV) | Aptivus |
| Fusion inhibitors | |
| Enfuvirtide (ENF or T-20) | Fuzeon |
| CCR5 antagonists | |
| Maraviroc (MRV) | Selzentry |
| Integrase inhibitors | |
| Raltegravir (RAL) | Isentress |